Fiduciary/Claymore Infrastructure Fund EBITDA margin
What is the EBITDA margin of Fiduciary/Claymore Infrastructure Fund?
The EBITDA margin of Fiduciary/Claymore Energy Infrastructure Fund is -466.20%
What is the definition of EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin of companies in the Finance sector on NYSE compared to Fiduciary/Claymore Infrastructure Fund
What does Fiduciary/Claymore Infrastructure Fund do?
Fiduciary/Claymore Energy Infrastructure Fund is a closed ended equity mutual fund launched and managed by Guggenheim Funds Investment Advisors, LLC.
Companies with ebitda margin similar to Fiduciary/Claymore Infrastructure Fund
- Theralase Technologies has EBITDA margin of -476.04%
- Sangamo Therapeutics Inc has EBITDA margin of -474.14%
- Xinyang Maojian has EBITDA margin of -471.45%
- WANdisco Plc has EBITDA margin of -470.42%
- RYU Apparel has EBITDA margin of -468.27%
- Barra Resources has EBITDA margin of -466.28%
- Fiduciary/Claymore Infrastructure Fund has EBITDA margin of -466.20%
- SRAX Inc has EBITDA margin of -465.79%
- Xtract One Technolgies Inc has EBITDA margin of -464.36%
- Spruce Biosciences has EBITDA margin of -462.16%
- Sage Therapeutics Inc has EBITDA margin of -460.83%
- Arcimoto Inc has EBITDA margin of -460.40%
- Canopy Rivers has EBITDA margin of -458.36%